FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4284890140> ?p ?o ?g. }

• W4284890140 abstract "Background Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer with limited treatment options and poor prognosis. Capecitabine, as a novel adjuvant chemotherapy for TNBCs, remains controversial. Therefore, we conducted this meta-analysis to assess the efficacy and safety of capecitabine for early-stage TNBCs combined with neo-/adjuvant chemotherapy. Methods We searched Medline, Embase, Web of Science, and Cochrane databases updated on Mar 18, 2022 for relevant RCTs. In all, 11 RCTs with 5,175 patients were included. We used hazard ratios (HRs) and odds ratios (ORs) to assess the differences between disease-free survival (DFS), overall survival (OS), and adverse events. Results Our study demonstrated significance differences in both DFS and OS (DFS: HR=0.77; 95% CI 0.68–0.86; OS: HR=0.73, 95% CI 0.63–0.85). In subgroup analysis, the lower dosage group showed higher DFS (HR=0.79, 95% CI 0.69–0.91), higher frequency (HR=0.72, 95%CI 0.62–0.83), and adjuvant chemotherapy (HR=0.74, 95% CI 0.65–0.84). However, capecitabine was also associated with a higher risk of diarrhea (OR=3.10, 95% CI 2.32–4.15), hand–foot syndrome (OR=25.79, 95% CI 15.32–43.42), and leukopenia (OR=2.08, 95% CI 1.13–3.84). Conclusion The addition of capecitabine to early-stage TNBC patients receiving standard adjuvant chemotherapy showed significant DFS and OS improvement with tolerable adverse events. The lower dosage and higher frequency of capecitabine combined with adjuvant chemotherapy demonstrated a better survival outcome." @default.
• W4284890140 created "2022-07-09" @default.
• W4284890140 creator A5006597525 @default.
• W4284890140 creator A5022384521 @default.
• W4284890140 creator A5028692173 @default.
• W4284890140 creator A5034914982 @default.
• W4284890140 creator A5036011791 @default.
• W4284890140 creator A5054519038 @default.
• W4284890140 creator A5086321789 @default.
• W4284890140 date "2022-07-07" @default.
• W4284890140 modified "2023-10-01" @default.
• W4284890140 title "Efficacy and Safety of Capecitabine for Triple-Negative Breast Cancer: A Meta-Analysis" @default.
• W4284890140 cites W1534401608 @default.
• W4284890140 cites W1989753015 @default.
• W4284890140 cites W1995224853 @default.
• W4284890140 cites W2029883816 @default.
• W4284890140 cites W2044970916 @default.
• W4284890140 cites W2047902191 @default.
• W4284890140 cites W2057550630 @default.
• W4284890140 cites W2070086300 @default.
• W4284890140 cites W2079411569 @default.
• W4284890140 cites W2083907066 @default.
• W4284890140 cites W2090806526 @default.
• W4284890140 cites W2096027508 @default.
• W4284890140 cites W2099526720 @default.
• W4284890140 cites W2107328434 @default.
• W4284890140 cites W2113947048 @default.
• W4284890140 cites W2114264989 @default.
• W4284890140 cites W2117151785 @default.
• W4284890140 cites W2138577761 @default.
• W4284890140 cites W2144309103 @default.
• W4284890140 cites W2145896038 @default.
• W4284890140 cites W2152793272 @default.
• W4284890140 cites W2165982376 @default.
• W4284890140 cites W2474664935 @default.
• W4284890140 cites W2528523319 @default.
• W4284890140 cites W2591793336 @default.
• W4284890140 cites W2609829394 @default.
• W4284890140 cites W2612866419 @default.
• W4284890140 cites W2618058692 @default.
• W4284890140 cites W2912993657 @default.
• W4284890140 cites W2963041253 @default.
• W4284890140 cites W2965236776 @default.
• W4284890140 cites W2993532690 @default.
• W4284890140 cites W2995588045 @default.
• W4284890140 cites W3015248490 @default.
• W4284890140 cites W3022903699 @default.
• W4284890140 cites W3110870031 @default.
• W4284890140 cites W3121634845 @default.
• W4284890140 cites W3172346887 @default.
• W4284890140 cites W2911150495 @default.
• W4284890140 doi "https://doi.org/10.3389/fonc.2022.899423" @default.
• W4284890140 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35875141" @default.
• W4284890140 hasPublicationYear "2022" @default.
• W4284890140 type Work @default.
• W4284890140 citedByCount "2" @default.
• W4284890140 countsByYear W42848901402023 @default.
• W4284890140 crossrefType "journal-article" @default.
• W4284890140 hasAuthorship W4284890140A5006597525 @default.
• W4284890140 hasAuthorship W4284890140A5022384521 @default.
• W4284890140 hasAuthorship W4284890140A5028692173 @default.
• W4284890140 hasAuthorship W4284890140A5034914982 @default.
• W4284890140 hasAuthorship W4284890140A5036011791 @default.
• W4284890140 hasAuthorship W4284890140A5054519038 @default.
• W4284890140 hasAuthorship W4284890140A5086321789 @default.
• W4284890140 hasBestOaLocation W42848901401 @default.
• W4284890140 hasConcept C121608353 @default.
• W4284890140 hasConcept C126322002 @default.
• W4284890140 hasConcept C143998085 @default.
• W4284890140 hasConcept C156957248 @default.
• W4284890140 hasConcept C197934379 @default.
• W4284890140 hasConcept C207103383 @default.
• W4284890140 hasConcept C2776694085 @default.
• W4284890140 hasConcept C2777909004 @default.
• W4284890140 hasConcept C2780110267 @default.
• W4284890140 hasConcept C44249647 @default.
• W4284890140 hasConcept C526805850 @default.
• W4284890140 hasConcept C530470458 @default.
• W4284890140 hasConcept C71924100 @default.
• W4284890140 hasConcept C90924648 @default.
• W4284890140 hasConcept C95190672 @default.
• W4284890140 hasConceptScore W4284890140C121608353 @default.
• W4284890140 hasConceptScore W4284890140C126322002 @default.
• W4284890140 hasConceptScore W4284890140C143998085 @default.
• W4284890140 hasConceptScore W4284890140C156957248 @default.
• W4284890140 hasConceptScore W4284890140C197934379 @default.
• W4284890140 hasConceptScore W4284890140C207103383 @default.
• W4284890140 hasConceptScore W4284890140C2776694085 @default.
• W4284890140 hasConceptScore W4284890140C2777909004 @default.
• W4284890140 hasConceptScore W4284890140C2780110267 @default.
• W4284890140 hasConceptScore W4284890140C44249647 @default.
• W4284890140 hasConceptScore W4284890140C526805850 @default.
• W4284890140 hasConceptScore W4284890140C530470458 @default.
• W4284890140 hasConceptScore W4284890140C71924100 @default.
• W4284890140 hasConceptScore W4284890140C90924648 @default.
• W4284890140 hasConceptScore W4284890140C95190672 @default.
• W4284890140 hasLocation W42848901401 @default.
• W4284890140 hasLocation W42848901402 @default.
• W4284890140 hasLocation W42848901403 @default.
• W4284890140 hasOpenAccess W4284890140 @default.

• next